News for Lantheus Holdings, Inc. (LNTH)

Strengths: Lantheus Holdings Inc's robust product portfolio and strategic acquisitions position it as a leader in radiopharmaceutical diagnostics and oncology.

Fourth Quarter Revenue: $391.1 million, an increase of 10.5% year over year.Full Year Revenue: $1.534 billion, an increase of 18.3% year over year.PYLARIFY Sal

Feb 26, 2025 / 01:00PM GMTOperator Good morning. Welcome to the Lantheus fourth quarter and full year 2024 conference call. (Operator Instructions) This call is

U.S. stocks were mixed, with the Dow Jones falling over 150 points on Wednesday. Shares of Workday, Inc. WDAY rose sharply during Tuesday's session after the c...

Shares of Lantheus Holdings Inc (LNTH) surged 18.64% in mid-day trading on Feb 26. The stock reached an intraday high of $96.81, before settling at $94.97,

Lantheus Holdings, Inc. (NASDAQ:LNTH) Q4 2024 - Earnings Conference Call February 26, 2025 8:00 AM ETCompany ParticipantsMark Kinarney - VP of IRBrian...

The following slide deck was published by Lantheus Holdings, Inc.

Worldwide revenue of $391.1 million and $1.53 billion for the fourth quarter and full year 2024Free cash flow was $141.4 million and $493.1 million for the four

Lantheus Holdings Inc (LNTH) is set to release its Q4 2024 earnings on Feb 26, 2025. The consensus estimate for Q4 2024 revenue is $375.43 million, and the earn

Lantheus Holdings Inc (LNTH), a prominent radiopharmaceutical-focused company dedicated to enhancing patient outcomes through innovative solutions, announced on

**media[546621]**

On December 31, 2024, Janus Henderson Group PLC executed a significant transaction by acquiring an additional 2,610,118 shares of Lantheus Holdings Inc. This mo

Lantheus Holdings Inc (LNTH), a leading radiopharmaceutical company, has announced it will host a conference call and webcast on February 26, 2025, at 8:00 a.m.

BEDFORD, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the ”œCompany”) ( LNTH) today announced that it will host a conference call and

On January 30, 2025, Portolan Capital Management, LLC (Trades, Portfolio) made a strategic move by acquiring 770,763 shares of Vishay Precision Group Inc (VPG)

We recently compiled a list of the 12 Best Low Risk High Growth Stocks to Invest In. In this article, we are going to take a look at where Lantheus Holdings, Inc.

Radiopharmaceutical specialist Lantheus Holdings (NASDAQ: LNTH) had some news to report Tuesday morning, but the market didn't greet it warmly. Well before market open that morning, Lantheus announced that it has signed a definitive agreement to acquire clinical-stage peer Evergreen Theragnostics. For its new asset, Lantheus will make an up-front cash payment of $250 million, and is to be on the hook for up to $725.5 million more if and when a series of milestone payments are earned by Evergreen.

**media[525951,525952]**

On January 15, 2025, James Thrall, a Director at Lantheus Holdings Inc (LNTH), sold 1,000 shares of the company, according to a SEC Filing. Following this trans